Based on its receptor status, breast cancer can be classified into estrogen receptor (ER)-positive, progesterone receptor (PR)-positive, human epidermal receptor 2 (HER2)-amplified, and triple-negative breast cancer which is lack of the former three biomarkers (2). This evidence concerns the gene PGR and breast carcinoma.